Verification of the usefulness of soft Micro Pore Filter: S-MPF, a filtration membrane that separates novel rare cells, in the extraction of peripheral blood circulation tumor cells (CTC) in lung cancer patients

UMIN ID: UMIN000047648

Registered date:04/05/2022

Basic Information

• Recruitment status: Complete: follow-up continuing
• Health condition(s) or Problem(s) studied: Lung cancer
• Date of first enrollment: 2021/11/09
• Target sample size: 25
• Countries of recruitment: Japan
• Study type: Interventional
• Intervention(s): CTC extraction by S-MPF: 15ml whole blood

Outcome(s)

• Primary Outcome: CTC detection rate

Key inclusion & exclusion criteria

• Age minimum: 20years-old
• Age maximum: 85years-old
• Gender: Male and Female
• Exclude criteria: 1) Active malignant tumors (simultaneous malignant tumors and hesichotic malignancies with a disease-free period of less than 5 years). However, lesions equivalent to Carcinoma in situ (intraepithelial cancer) and intramucosal cancer, which are judged to be cured by topical treatment, are not included in active malignant tumors). 2) Patients with infectious diseases requiring systemic treatment, including HIV, HBV, and HCV infections. 3) Without using an antipyretic, there is a fever of 38 centi digree or more at axillary temperature within 24 hours before registration. 4) Continuous systemic administration (internal or intravenous) of steroids or other immunosuppressants. 5) Cases in which the attending physician deems it inappropriate to carry out this study

Related Information

• Primary Sponsor: Nara Medical University
• Source(s) of Monetary Support: Nara Medical University